BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6450559)

  • 1. Elevated fibrin(ogen) degradation products in the adult respiratory distress syndrome.
    Haynes JB; Hyers TM; Giclas PC; Franks JJ; Petty TL
    Am Rev Respir Dis; 1980 Dec; 122(6):841-7. PubMed ID: 6450559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial injuries and changes of blood coagulation and fibrinolysis indexes in patients with acute respiratory distress syndrome.
    He XL; Liu Z; Xia SY
    Chin Med Sci J; 2004 Dec; 19(4):252-6. PubMed ID: 15669181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.
    Carvalho AC; DeMarinis S; Scott CF; Silver LD; Schmaier AH; Colman RW
    J Lab Clin Med; 1988 Aug; 112(2):270-7. PubMed ID: 3397629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet and fibrin metabolism in recipients of the Jarvik 7 total artificial heart.
    Ring ME; Feinberg WM; Levinson MM; Bruck DC; Smith RG; Icenogle TM; Copeland JG
    J Heart Transplant; 1989; 8(3):225-32. PubMed ID: 2525612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
    J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of mediators by limited proteolysis during blood coagulation and fibrinolysis--its pathogenetic role in the adult respiratory distress syndrome (ARDS).
    Neuhof H; Seeger W; Wolf HR
    Resuscitation; 1986 Sep; 14(1-2):23-32. PubMed ID: 3024276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation in patients at risk of developing the adult respiratory distress syndrome.
    Duchateau J; Haas M; Schreyen H; Radoux L; Sprangers I; Noel FX; Braun M; Lamy M
    Am Rev Respir Dis; 1984 Dec; 130(6):1058-64. PubMed ID: 6508004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolysis in critically ill patients.
    Moalli R; Doyle JM; Tahhan HR; Hasan FM; Braman SS; Saldeen T
    Am Rev Respir Dis; 1989 Aug; 140(2):287-93. PubMed ID: 2504087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome.
    Fuchs-Buder T; de Moerloose P; Ricou B; Reber G; Vifian C; Nicod L; Romand JA; Suter PM
    Am J Respir Crit Care Med; 1996 Jan; 153(1):163-7. PubMed ID: 8542111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen, fibrin(ogen) degradation products and fibrinopeptide A in pleural effusions. High turnover of fibrinogen in pleurisy.
    Widström O; Kockum C; Nilsson BS
    Scand J Respir Dis; 1978 Aug; 59(4):210-5. PubMed ID: 694476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased intravascular coagulation associated with pregnancy.
    Gerbasi FR; Bottoms S; Farag A; Mammen E
    Obstet Gynecol; 1990 Mar; 75(3 Pt 1):385-9. PubMed ID: 2137574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment.
    Douglas JT; Blamey SL; Lowe GD; Carter DC; Forbes CD
    Thromb Haemost; 1985 Apr; 53(2):235-8. PubMed ID: 2410995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in hemostasis activity during delivery and the immediate postpartum period.
    Gerbasi FR; Bottoms S; Farag A; Mammen EF
    Am J Obstet Gynecol; 1990 May; 162(5):1158-63. PubMed ID: 2140236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
    Nakajima H
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of circulating endotoxin with the development of the adult respiratory distress syndrome.
    Parsons PE; Worthen GS; Moore EE; Tate RM; Henson PM
    Am Rev Respir Dis; 1989 Aug; 140(2):294-301. PubMed ID: 2764364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever.
    Rao AK; Schapira M; Clements ML; Niewiarowski S; Budzynski AZ; Schmaier AH; Harpel PC; Blackwelder WC; Scherrer JR; Sobel E
    N Engl J Med; 1988 Apr; 318(16):1021-8. PubMed ID: 2965302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man.
    Solomkin JS; Cotta LA; Satoh PS; Hurst JM; Nelson RD
    Surgery; 1985 Jun; 97(6):668-78. PubMed ID: 4002115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of fibrinogen derivatives in plasma in human renal failure.
    Lane DA; Ireland H; Knight I; Wolff S; Kyle P; Curtis JR
    Br J Haematol; 1984 Feb; 56(2):251-60. PubMed ID: 6229269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
    Roy MS; Podgor MJ; Rick ME
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the complement system in the adult respiratory distress syndrome.
    Robbins RA; Russ WD; Rasmussen JK; Clayton MM
    Am Rev Respir Dis; 1987 Mar; 135(3):651-8. PubMed ID: 3826891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.